Eurofins Scientific Aktie [WKN DE: A2QJCT / ISIN: FR0014000MR3]

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (groß)	News + Adhoc	Bilanz/GuV	Termine	Zertifikate	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Optionsscheine	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV	Knock-Outs
Orderbuch	Analysen
Historisch

Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Orderbuch
Historisch

News + Analysen
News + Adhoc
Analysen
Kursziele

Fundamental
Bilanz/GuV
Schätzungen
Dividende/GV
Analysen

Unternehmen
Termine
Profil

zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs

Nachrichten zu Eurofins Scientific SE

17.07.23		CAC 40-Wert Eurofins Scientific SE-Aktie: So viel hätten Anleger an einem frühen Eurofins Scientific SE-Investment verdient (finanzen.at)
07.06.23		Eurofins Environment Testing Wastewater Surveillance Program can play a Vital Role in Monitoring Initiatives to Identify Illicit Narcotics and Opioid Usage (Businesswire)
16.05.23		New Study finds Volumetric Absorptive Micro-Samplers (VAMS) Prove to be Useful Self-Collection Tools for Assessing Human Exposure to PFAS (Businesswire)
20.02.23		Eurofins Companies Launch SARS-CoV-2 Variant XBB.1.5 Droplet Digital PCR Assay (ddPCR) for Wastewater Surveillance (Businesswire)
16.02.23		Eurofins Viracor Launches Ground-Breaking Test for Assessing Expansion and Persistence of CAR-T Therapy in Cancer Patients (Businesswire)
27.10.22		Eurofins Celebrates 35 Years of Testing for Life and 25 Years as Best Performing Share Listed in Europe (Businesswire)
27.09.22		Eurofins Sacramento, in Collaboration with SCIEX USA, Achieves the Lowest Detection Limits for PFAS in Drinking Water (Businesswire)
24.06.22		Gold Standard Diagnostics, ein Unternehmen von Eurofins Technologies, kündigt einen PCR-Test zum Nachweis des Affenpocken- und Orthopockenvirus an (Businesswire)
23.06.22		Gold Standard Diagnostics, a Eurofins Technologies Company, Announces a PCR Assay for the Detection of the Monkeypox and Orthopox Virus (Businesswire)
21.06.22		Eurofins Successfully Prices New €600m 7-Year 4%-Coupon Senior Unsecured Bonds (Businesswire)
24.05.22		Nation’s PFAS Testing Leader, Eurofins Environment Testing USA, One of the First Commercial Laboratories to receive Accreditation for Draft Method 1633 (Businesswire)
10.05.22		Health Canada approves Eurofins CDMO Alphora Inc.’s Standard Processing License for Synthetic Phytocannabinoids (Businesswire)
09.05.22		PAMM Foundation Outsources Its Laboratory Activities for Pathology and Medical Microbiology ("PAMM”) to Eurofins Clinical Diagnostics Netherlands (Businesswire)
08.03.22		Eurofins Genomics wird die Genotypisierung von bis zu 5 Millionen Teilnehmern an "Our Future Health", dem bislang größten Gesundheitsforschungsprogramm des Vereinigten Königreichs, durchführen (Businesswire)
08.03.22		Eurofins Genomics Will Be Conducting Genotyping for up to 5 Million Participants of Our Future Health, UK’s Largest Ever Health Research Programme (Businesswire)
09.07.21		Eurofins and Rite Aid Launch an Over-the-Counter, FDA-Authorised, at-Home COVID-19 PCR Test in all Rite Aid Locations in the U.S. (Businesswire)
08.07.21		Eurofins Viracor Invests in Innovation with the Launch of Coronavirus (COVID-19) SARS-CoV-2 inSIGHT™ T Cell Immunity Testing (Businesswire)
02.07.21		Eurofins Develops Most Comprehensive COVID-19 Testing Network in the UK to Enable International Travel (Businesswire)
02.07.21		Eurofins Opens Europe-Wide COVID-19 Testing Centre Network to Facilitate Summer Travel (Businesswire)
27.05.21		Eurofins Awarded U.S. Government Agreement to Expand National Covid-19 Testing (Businesswire)
25.05.21		Eurofins Expands Its Global Sequencing and Mutation-Specific PCR Capabilities to Detect COVID-19 Variants of Concern and of Interest (Businesswire)
17.05.21		Eurofins at the Forefront of Innovation with New Developments for Detection and Identification of Emerging COVID-19 Variants of Concern (Businesswire)
13.05.21		Eurofins Supports Reopening of UK Travel With Launch of Affordable Day 2 & 8 Testing Services (Businesswire)
07.05.21		EAG erweitert Prüfdienstleistungen für Medizinprodukte mit neuem Labor (Businesswire)
07.05.21		EAG Expands Medical Device Testing Services with New Laboratory (Businesswire)
26.04.21		Eurofins Subsidiary empowerDX and Uber Team up, Offer At-home COVID-19 Testing Kits via On-demand Delivery in More Than Two Dozen U.S. Cities (Businesswire)
13.04.21		Eurofins Covid Testing Services Ltd (ECTS) Supports Reopening UK Travel by Making PCR Testing Affordable for All (Businesswire)
22.03.21		Eurofins Technologies Launches an Enhanced Variant of Concern-Discriminating PCR Test Including the South African Variant (B.1.351) (Businesswire)
12.03.21		Eurofins Adds Virus Variant Detection to its SARS-CoV-2 Monitoring Solution for Wastewater, Surface, Air and Worn Masks (Businesswire)
10.03.21		Eurofins Launches empowerDX COVID-19 Home Collection Kit on Amazon (Businesswire)
01.03.21		Nation’s PFAS Leader, Eurofins, Expands Reporting to 75 Compounds (Businesswire)
01.03.21		Eurofins Announces the launch of an At-Home COVID-19 PCR Test kit available direct to consumers, without prescription (Businesswire)
01.03.21		Eurofins Announces the launch of an At-Home COVID-19 PCR Test kit available direct to consumers, without prescription (Businesswire)
18.02.21		Eurofins Scientific Announces Acquisition of Beacon Discovery, Substantially Expanding Its Integrated Drug Discovery Capabilities and Expertise (Businesswire)
17.02.21		Eurofins Adds Virus Variant Distinction to Its SARS-CoV-2 Monitoring Solution for Wastewater, Food and Environmental Surfaces (Businesswire)
16.02.21		Eurofins Forensics Adds Significant COVID-19 Testing Capacity to the UK With Home Testing Roll-Out (Businesswire)
11.02.21		Eurofins Launches Quantitative Antibody Test to Measure Immune Response to COVID-19 and Vaccines (Businesswire)
03.02.21		Eurofins spendet 100.000 PCR-Schnelltests zum Nachweis der SARS-CoV-2 Varianten B.1.1.7 (ex. GB), B.1.351 (ex. Südafrika) und B1.1.248 (ex. Brasilien) an Krankenhäuser weltweit (PR Newswire)
02.02.21		Eurofins donates 100,000 fast PCR tests to detect SARS-CoV-2 variants B.1.1.7 (ex. UK), B.1.351 (ex. South Africa) and B1.1.248 (ex. Brazil) to hospitals around the world (PR Newswire)
02.02.21		Eurofins donates 100,000 fast PCR tests to detect SARS-CoV-2 variants B.1.1.7 (ex. UK), B.1.351 (ex. South Africa) and B1.1.248 (ex. Brazil) to hospitals around the world (PR Newswire)
02.02.21		Eurofins Donates 100,000 Fast PCR Tests to Detect SARS-CoV-2 Variants B.1.1.7 (ex. UK), B.1.351 (ex. South Africa) and B.1.1.248 (ex. Brazil) to Hospitals Around the World (Businesswire)
28.01.21		Eurofins Offers a New Molecular Solution to Detect SARS-CoV-2 variants B.1.1.7 (UK) and B.1.351 (South Africa) (Businesswire)
25.01.21		Eurofins Achieved Revenues in Excess of EUR 5.4bn in 2020, After Continued Momentum in December Across Both Its Core Business and COVID-19 Related Activities (Businesswire)
15.01.21		Eurofins, weltweit führender Anbieter von analytischen Prüfungen, erweitert seine weltweiten Prüf- und Zertifizierungskapazitäten für Gesichtsmasken (Businesswire)
11.01.21		Eurofins GeneScan Technologies Announces AOAC PTM Accreditation for the VIRSeek SARS-CoV-2 Detection Workflow on Environmental Surfaces under the AOAC SARS-CoV-2 Emergency Response Validation Program (Businesswire)
28.12.20		Eurofins Genomics Launches Cost-Effective SARS-CoV-2 full-length Viral Genome Sequencing Services Essential in the Identification of Viral Mutations (Businesswire)
22.12.20		Eurofins Launches COVID-19 PCR Tests With At-Home Self-Sampling Options in Europe and Donates Sequencing Capacity to Identify VUI-2020-12/01 Strain Reported to Spread Faster in the UK (Businesswire)
15.12.20		Eurofins Raises Its 2020 Objectives After Strong Momentum in Its Core Business, as Well as in COVID-19 Related Activities in October and November (Businesswire)
14.12.20		Eurofins Technologies Launches New and Improved Lateral Flow Device Product Line for Allergen Detection in Foodstuffs and Environmental Samples (Businesswire)
14.12.20		Eurofins Launches a Rapid SARS-CoV-2 Antigen Test and a RT-PCR Test in a Self-Sampled, Gargling Format (Businesswire)

Zurück | 1 | 2 | 3 | 4 | Weiter

Newssuche

Eurofins Scientific Peer Group Nachrichten

18.02.25		Gute Stimmung in Paris: CAC 40 beendet die Sitzung im Plus
18.02.25		Euronext-Handel: CAC 40 verbucht am Nachmittag Gewinne
18.02.25		Minuszeichen in Paris: So bewegt sich der CAC 40 mittags
18.02.25		Börse Paris in Grün: CAC 40 präsentiert sich zum Start des Dienstagshandels fester
17.02.25		Handel in Paris: CAC 40 zeigt sich schlussendlich fester
17.02.25		Pluszeichen in Paris: CAC 40 am Montagnachmittag mit grünem Vorzeichen
17.02.25		Pluszeichen in Paris: CAC 40 am Mittag mit positivem Vorzeichen
17.02.25		Börse Paris: CAC 40 zeigt sich zum Start leichter

Portfolioname: Watchlistname:
Portfolio:
Name:
Typ:
ISIN:
Börse:
Anzahl:
Aktueller Kurs:
Kurszeit:
Kaufpreis:
Kaufdatum:	19.02.2025 01:38
Kaufwert:	EUR
	Hinzufügen Speichern

Eurofins Scientific Aktie [WKN DE: A2QJCT / ISIN: FR0014000MR3]

Nachrichten zu Eurofins Scientific SE

Newssuche

Eurofins Scientific Peer Group Nachrichten

Meistgelesene Nachrichten